US FDA advisers back Pfizer COVID treatment for full approval
Advisers to the U.S. Food and Drug Administration on Thursday overwhelmingly backed Pfizer’s oral antiviral COVID-19 treatment Paxlovid for full approval in adults at high risk of progression to severe disease. The FDA’s panel of outside experts voted 16-to-1 in favor of the drug’s benefits, outweighing its risk for some adults with mild-to-moderate COVID-19. The […]
The post US FDA advisers back Pfizer COVID treatment for full approval appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.